However, the mechanisms of action of thalidomide are not yet entirely clear, its benefit has primarily been ascribed to its roles as an anti-TNF-alpha agent and reduce TNF-α, IL-6 and IL-1β production in colon homogenate of experimental colitis (Fakhoury et al., 2014). Here, IL1B is linked to colitis.